Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 12/20 | 0.62 |
| ▸ | ESR2 | Q92731 | 12/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.44 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4319988 | 1.00 | ESR1 (0.62) | ESR1ESR2TSHRALDH1A1MEN1 | |
| SCHEMBL7262475 | 1.00 | ESR1 (0.62) | ESR1ESR2TSHRALDH1A1MEN1 | |
| SCHEMBL6056000 | 0.91 | TSHR (0.79) | ESR1ESR2TSHRALDH1A1MEN1 | |
| SCHEMBL6689869 | 0.78 | TSHR (0.60) | ESR1ESR2TSHRCYP1A2CYP2C19 | |
| SCHEMBL6908022 | 0.78 | TSHR (0.60) | ESR1ESR2TSHRALDH1A1KMT2A | |
| SCHEMBL8019231 | 0.78 | TSHR (0.60) | ESR1ESR2TSHRALDH1A1MEN1 | |
| SCHEMBL199580 | 0.78 | TSHR (0.60) | ESR1ESR2TSHRALDH1A1KMT2A | |
| SCHEMBL2164185 | 0.78 | TSHR (0.60) | ESR1ESR2TSHRCYP1A2CYP2C19 | |
| SCHEMBL8020863 | 0.78 | TSHR (0.60) | ESR1ESR2TSHRALDH1A1MEN1 | |
| SCHEMBL6688835 | 0.78 | TSHR (0.60) | ESR1ESR2TSHRALDH1A1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117169388-A | Method for predicting optimal recovery period of Chinese yam by using marker metabolite model based on machine learning | 河南省农业科学院农产品质量安全研究所 | 2023-12-05 | — | — | CN | claimed |
| CN-112888498-B | Composition useful for making acid gas separation membranes | 住友化学株式会社 | 2023-07-14 | — | — | CN | claimed |
| EP-3862072-A1 | COMPOSITION USEFUL FOR PRODUCTION OF ACIDIC GAS SEPARATION MEMBRANE | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2021-08-11 | — | — | EP | claimed |
| CN-112888498-A | Composition useful for producing acid gas separation membranes | 住友化学株式会社 | 2021-06-01 | — | — | CN | claimed |
| WO-2020071411-A1 | COMPOSITION USEFUL FOR PRODUCTION OF ACIDIC GAS SEPARATION MEMBRANE | 住友化学株式会社 | 2020-04-09 | — | — | WO | claimed |
| EP-1649029-B1 | A METHOD OF PRODUCING A LOW MOLECULAR WEIGHT PLANT SECONDARY METABOLITE IN A YEAST CELL | EVOLVA SA (CH) | 2014-12-17 | — | — | EP | claimed |
| EP-1234046-B1 | UDP-GLUCOSE:AGLYCON-GLUCOSYLTRANSFERASE | ADELAIDE RES & INNOVATION PTY (AU) | 2008-11-12 | — | — | EP | claimed |
| US-7122657-B2 | UDP-glucose aglycon-glucosytransferase | MOLLER, BIRGER LINDBERG (DK) | 2006-10-17 | — | — | US | claimed |
| US-20050277766-A1 | Udp-glucose aglycon-glucosytransferase | MOLLER, BIRGER LINDBERG (DK) | 2005-12-15 | — | — | US | claimed |
| EP-1234046-A2 | UDP-GLUCOSE:AGLYCON-GLUCOSYLTRANSFERASE | LUMINIS PTY. LIMITED (AU) | 2002-08-28 | — | — | EP | claimed |
| WO-2001040491-A2 | UDP-GLUCOSE:AGLYCON-GLUCOSYLTRANSFERASE | LUMINIS PTY, LIMITED (AU) | 2001-06-07 | — | — | WO | claimed |
| EP-0610048-B1 | Process for producing optically active alpha-hydrocarboxylic acid having phenyl group | MITSUBISHI RAYON CO (JP) | 1999-09-22 | — | — | EP | claimed |
| US-5580765-A | A CULTURE PRODUCT OF A-HYDROXYNITRILE OR A MIXTURE OF ALDEHYDE AND PRUSSIC ACID | NITTO CHEMICAL INDUSTRY CO., LTD. (JP) | 1996-12-03 | — | — | US | claimed |
| EP-0610048-A2 | Process for producing optically active alpha-hydrocarboxylic acid having phenyl group | NITTO CHEMICAL INDUSTRY CO., LTD. (JP) | 1994-08-10 | — | — | EP | claimed |
| CN-117740961-A | Compound analysis method of liquorice and liquorice probiotics fermentation preparation | 北京中医药大学 | 2024-03-22 | — | — | CN | disclosed |
| CN-117169388-A | Method for predicting optimal recovery period of Chinese yam by using marker metabolite model based on machine learning | 河南省农业科学院农产品质量安全研究所 | 2023-12-05 | — | — | CN | disclosed |
| US-20230365730-A1 | HIGH TEMPERATURE BENZOXAZINE RESINS, METHODS, AND USES THEREOF | KANEKA CORPORATION (JP) | 2023-11-16 | — | — | US | disclosed |
| EP-0326063-A2 | Process for the preparation of optically active cyanhydrins | FORSCHUNGSZENTRUM JÜLICH GMBH (DE) | 1989-08-02 | — | — | EP | disclosed |
| US-4837293-A | Linear bisphenol epoxy polymers containing cyano groups | THE DOW CHEMICAL COMPANY (US) | 1989-06-06 | — | — | US | disclosed |
| US-4198523-A | SODIUM OR POTASSIUM. SOLID INTERMEDIATE FOR ATENOLOL | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1980-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365730-A1 | HIGH TEMPERATURE BENZOXAZINE RESINS, METHODS, AND USES THEREOF | KDM5C, DHX15, KDM5A | ESR1 364/4885ESR2 1689/4885TSHR 4059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.